Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02081235
Other study ID # 2013-12-101
Secondary ID
Status Completed
Phase N/A
First received March 5, 2014
Last updated June 14, 2016
Start date June 2014
Est. completion date February 2016

Study information

Verified date June 2016
Source Samsung Medical Center
Contact n/a
Is FDA regulated No
Health authority South Korea: Institutional Review Board
Study type Observational

Clinical Trial Summary

Acute kidney injury (AKI) is a major complication after cardiac surgery and has been reported to be associated with adverse outcome. Previous studies have reported that the incidence of AKI in patients undergoing surgery for congenital heart disease is as high as 42% and AKI increase the patient mortality, intensive care unit stay and hospital stay. Previous studies have reported several risk factors for AKI after congenital heart surgery, however, perioperative variables including anesthesia-related factors have not been evaluated fully. Therefore, the investigators attempt to find out independent risk factors regarding perioperative variables.


Description:

Acute kidney injury (AKI) is a major complication after cardiac surgery and has been reported to be associated with adverse outcome. Previous studies have reported that the incidence of AKI in patients undergoing surgery for congenital heart disease is as high as 42% and AKI increase the patient mortality, intensive care unit stay and hospital stay. Previous studies have reported several risk factors for AKI after congenital heart surgery, however, perioperative variables including anesthesia-related factors have not been evaluated fully. In addition, a neutrophil-lymphocyte ratio (NLR), which have been reported to be a marker for systemic inflammation and associated with prognosis of cardiac and cancer patients might be able to predict development of postoperative AKI. Therefore, the investigators attempt to assess independent risk factors regarding perioperative variables including transfusion-related parameters, preoperative anemia, preoperative hypoalbuminemia, pulmonary hypertension, use of nitric oxide, use of hydroxyethyl starch, perioperative medication, hemodynamic variables and perioperative NLR.


Recruitment information / eligibility

Status Completed
Enrollment 220
Est. completion date February 2016
Est. primary completion date February 2016
Accepts healthy volunteers No
Gender Both
Age group N/A to 17 Years
Eligibility Inclusion Criteria:

- patients who underwent surgery for congenital heart disease between January 2012 and December 2012 in Samsung Medical Center

Exclusion Criteria:

- incomplete data for creatinine, estimated glomerular filtration rate, or urine output required to diagnose acute kidney injury

- patients who expired within 24 hours after surgery

Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Related Conditions & MeSH terms


Intervention

Procedure:
surgery for congenital heart disease
surgery for congenital heart disease

Locations

Country Name City State
Korea, Republic of Samsung Medical Center Seoul

Sponsors (1)

Lead Sponsor Collaborator
Samsung Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Acute kidney injury as defined by KDIGO (Kidney Disease: Improving Global outcome) criteria Acute kidney injury as defined by KDIGO criteria (Stage 1, 2, 3) during seven days after surgery Yes
Secondary Acute kidney injury as defined by AKIN (acute kidney injury network) criteria Acute kidney injury as defined by AKIN (acute kidney injury network) criteria within 48 hours after surgery within 48 hours after surgery Yes
Secondary acute kidney injury diagnosis defined by RIFLE criteria acute kidney injury diagnosis defined by RIFLE criteria (for Risk, Injury, Failure during seven days after surgery during seven days after surgery Yes